MARÍA
GALINDO IZQUIERDO
Profesora asociada de Ciencias de la Salud
Hospital Regional Universitario de Málaga
Málaga, EspañaPublicaciones en colaboración con investigadores/as de Hospital Regional Universitario de Málaga (25)
2023
-
Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)
Seminars in Arthritis and Rheumatism, Vol. 58
-
Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER)
Seminars in Arthritis and Rheumatism, Vol. 61
2022
-
Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure
Seminars in Arthritis and Rheumatism, Vol. 52
-
Clinical characteristics and risk factors associated with lymphoma in patients with systemic lupus erythematosus: a nationwide cohort study
Rheumatology (Oxford, England), Vol. 62, Núm. 1, pp. 217-224
-
Importance of family planning in patients with immune-mediated inflammatory diseases: a multidisciplinary approach
Reumatologia Clinica, Vol. 18, Núm. 4, pp. 200-206
2021
-
Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?
Clinical and Experimental Rheumatology, Vol. 39, Núm. 3, pp. 555-563
-
Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER)
Rheumatology (Oxford, England), Vol. 60, Núm. 4, pp. 1793-1803
-
Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?
Rheumatology (Oxford, England), Vol. 60, Núm. 11, pp. 5329-5336
2020
-
Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality
Lupus, Vol. 29, Núm. 12, pp. 1556-1565
-
Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: A multicentric matched cohort study
Annals of the Rheumatic Diseases, Vol. 79, Núm. 12, pp. 1544-1549
-
Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry)
Lupus, Vol. 29, Núm. 1, pp. 27-36
-
Hydroxychloroquine is associated with a lower risk of polyautoimmunity: Data from the RELESSER Registry
Rheumatology (United Kingdom), Vol. 59, Núm. 8, pp. 2043-2051
-
Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases
Annals of the Rheumatic Diseases, Vol. 79, Núm. 9, pp. 1170-1173
-
Recommendations of the Spanish Rheumatology Society for Primary Antiphospholipid Syndrome. Part I: Diagnosis, Evaluation and Treatment
Reumatologia Clinica, Vol. 16, Núm. 2P1, pp. 71-86
-
Recommendations of the Spanish Rheumatology Society for Primary Antiphospholipid Syndrome. Part II: Obstetric Antiphospholipid Syndrome and Special Situations
Reumatologia Clinica, Vol. 16, Núm. 2P2, pp. 133-148
2018
-
Expert recommendations on the psychological needs of patients with rheumatoid arthritis
Rheumatology International, Vol. 38, Núm. 12, pp. 2167-2182
-
Primary respiratory disease in patients with systemic lupus erythematosus: Data from the Spanish rheumatology society lupus registry (RELESSER) cohort
Arthritis Research and Therapy, Vol. 20, Núm. 1
2017
-
Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus
Seminars in Arthritis and Rheumatism, Vol. 47, Núm. 1, pp. 38-45
2016
-
Characterization of patients with lupus nephritis included in a large cohort from the Spanish society of rheumatology registry of patients with systemic lupus erythematosus (RELESSER)
Medicine (United States), Vol. 95, Núm. 9
-
Cut-offs and response criteria for the Hospital Universitario la Princesa Index (HUPI) and their comparison to widely-used indices of disease activity in rheumatoid arthritis
PLoS ONE, Vol. 11, Núm. 9